Successful use of agomelatine in the treatment of major depression in a woman taking tamoxifen: A case report

Clinical Neuropharmacology

Volumn 37, Issue 1, 2014, Pages 31-33

  De Berardis, Domenico ^a,b   Brucchi, Maurizio ^c   Serroni, Nicola ^a   Valchera, Alessandro ^d   Fornaro, Michele ^e   Mazza, Monica ^f   Martinotti, Giovanni ^b   Di Giannantonio, Massimo ^b  

^a Service of Diagnosis and Treatment   (Italy)

^b UNIVERSITY OF CHIETI   (Italy)

^c G Mazzini Hospital   (Italy)

^d Hermanas Hospitalarias   (Italy)

^e UNIVERSITY OF CATANIA   (Italy)

^f UNIVERSITY OF L'AQUILA   (Italy)

Author keywords

agomelatine; anhedonia; breast cancer; depression; tamoxifen

Indexed keywords

ACETAMIDES; ADULT; ANTIDEPRESSIVE AGENTS; CARCINOMA; DEPRESSIVE DISORDER, MAJOR; ESTROGEN ANTAGONISTS; FEMALE; HUMANS; TAMOXIFEN;

EID: 84895076938     PISSN: 03625664     EISSN: 1537162X     Source Type: Journal    
DOI: 10.1097/WNF.0000000000000009     Document Type: Article

References (19)

1. Lorizio W, Wu AH, Beattie MS, et al. Clinical and biomarker predictors of side effects from tamoxifen. Breast Cancer Res Treat 2012;132:1107-1118.
2. Lee KC, Ray GT, Hunkeler EM, et al. Tamoxifen treatment and new-onset depression in breast cancer patients. Psychosomatics 2007;48:205-210. (Pubitemid 46769624)
3. Cuzick J, Sestak I, Cella D, et al. Treatment-emergent endocrine symptoms and the risk of breast cancer recurrence: a retrospective analysis of the ATAC trial. Lancet Oncol 2008;9:1143-1148.
4. Srinivasan V, De Berardis D, Shillcutt SD, et al. Role of melatonin in mood disorders and the antidepressant effects of agomelatine. Expert Opin Investig Drugs 2012;21:1503-1522.
5. De Berardis D, Marini S, Fornaro M, et al. The melatonergic system in mood and anxiety disorders and the role of agomelatine: implications for clinical practice. Int J Mol Sci 2013;14: 12458-12483.
6. De Berardis D, Conti CM, Marini S, et al. Is there a role for agomelatine in the treatment of anxiety disorders? A review of published data. Int J Immunopathol Pharmacol 2013;26: 299-304.
7. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders DSM-IV-TR Fourth Edition, Text Revision. Washington, DC: American Psychiatric Association; 2000.
8. Binkhorst L, Mathijssen RH, van Herk-Sukel MP, et al. Unjustified prescribing of CYP2D6 inhibiting SSRIs in women treated with tamoxifen. Breast Cancer Res Treat 2013;139:923-929.
9. Wu X, Hawse JR, Subramaniam M, et al. The tamoxifen metabolite, endoxifen, is a potent anti-estrogen that targets estrogen receptor alpha for degradation in breast cancer cells. Cancer Res 2009;69: 1722-1727.
10. Breitbart W. Do antidepressants reduce the effectiveness of tamoxifen? Psychooncology 2011;20:1-4.
11. Dusetzina SB, Alexander GC, Freedman RA, et al. Trends in co-prescribing of antidepressants and tamoxifen among women with breast cancer, 2004-2010. Breast Cancer Res Treat 2013;137: 285-296.
12. Spina E, Trifirò G, Caraci F. Clinically significant drug interactions with newer antidepressants. CNS Drugs 2012;26:39-67.
13. Di Giannantonio M, Di Iorio G, Guglielmo R, et al. Major depressive disorder, anhedonia and agomelatine: an open-label study. J Biol Regul Homeost Agents 2011;25:109-114.
14. Martinotti G, Sepede G, Gambi F, et al. Agomelatine versus venlafaxine XR in the treatment of anhedonia in major depressive disorder: a pilot study. J Clin Psychopharmacol 2012;32: 487-491.
15. De Berardis D, Di Iorio G, Acciavatti T, et al. The emerging role of melatonin agonists in the treatment of major depression: focus on agomelatine. CNS Neurol Disord Drug Targets 2011;10:119-132.
16. Di Giannantonio M, Martinotti G. Anhedonia and major depression: the role of agomelatine. Eur Neuropsychopharmacol 2012;22 (Suppl 3):505-510.
17. DiazGranados N, Zarate CA Jr. A review of the preclinical and clinical evidence for protein kinase C as a target for drug development for bipolar disorder. Curr Psychiatry Rep 2008;10:510-519.
18. Abrial E, Etievant A, Bétry C, et al. Protein kinase C regulates mood-related behaviors and adult hippocampal cell proliferation in rats. Prog Neuropsychopharmacol Biol Psychiatry 2013;43:40-48.
19. Amrollahi Z, Rezaei F, Salehi B, et al. Double-blind, randomized, placebo-controlled 6-week study on the efficacy and safety of the tamoxifen adjunctive to lithium in acute bipolar mania. J Affect Disord 2011;129:327-331.